Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA approves world's smallest estrogen transdermal patch

Jan. 12, 1999

ThGRF1-44 enters clinical development at Theratechnologies

Jan. 12, 1999

Applications filed in U.S. and Europe for new osteoporosis drug

Jan. 11, 1999

Oxford GlycoSciences reports steady progress in OGT-918 development programs

Jan. 11, 1999

Terbutaline by infusion pump evaluated for preventing preterm delivery

Jan. 11, 1999

Novel cholesterol-lowering agent from Forbes Medi-Tech cleared for U.S. clinical trials

Jan. 11, 1999

Protease inhibitors especially useful for osteoporosis, periodontitis and arthritis reported by SB

Jan. 8, 1999

Metabolex enters into diabetes partnership with Parke-Davis

Jan. 8, 1999

Phase II trial results published for repaglinide for treatment of type II diabetes

Jan. 7, 1999

New antiobesity target a focus of attention at recent Japanese meeting

Jan. 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...